checkAd

    SHAREHOLDER ALERT  626  0 Kommentare Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Biogen Inc. to Contact the Firm

    NEW YORK, NY--(Marketwired - September 03, 2015) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) of the October 19, 2015 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

    A lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of a class consisting of all persons or entities who purchased Biogen securities between January 29, 2015 and July 23, 2015.

    The complaint alleges that the Company and its executives violated federal securities laws by failing to appropriately estimate the financial benefit from the sale of TECFIDERA, one of the Company's main drugs. Specifically, on July 24, 2015, the Company reported that it was amending its previously issued revenue growth projection of 14-16% for the first half of 2015 to around half that amount. Biogen cited the unexpected lack of sales growth in TECFIDERA as an important factor for the revision.

    After the announcement, Biogen's share price fell from a closing price of $385.05 per share on July 23, 2015, to a closing price of $300.03 per share on July 24, 2015 -- a drop of $85.02 or over 22%.

    Request more information now by clicking here: www.faruqilaw.com/BIIB. There is no cost or obligation to you.

    Take Action

    If you invested in Biogen stock or options between January 29, 2015 and July 23, 2015 and would like to discuss your legal rights, visit www.faruqilaw.com/BIIB. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Biogen's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

    Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

    FARUQI & FARUQI, LLP
    369 Lexington Avenue, 10th Floor
    New York, NY 10017
    Attn: Richard Gonnello, Esq.
    Email contact
    Telephone: (877) 247-4292 or (212) 983-9330




    Verfasst von Marketwired
    SHAREHOLDER ALERT Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Biogen Inc. to Contact the Firm NEW YORK, NY--(Marketwired - September 03, 2015) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) of the October 19, 2015 deadline to seek the role of lead …